Labetalol Monograph: α1/β Blockade, Severe Hypertension, Obstetric Use and Safety
Evidence-informed pharmacology monograph, reviewed 10 November 2026. Educational content; drug administration and prescribing require current local labels, institutional protocols and individualized clinical assessment. Overview and learning objectives Labetalol is a mixed adrenergic antagonist that blocks vascular α1 receptors and cardiac/bronchial β1 and β2 receptors. It is used orally for selected chronic hypertension regimens and intravenously…